|4Mar 22, 9:28 PM ET

VIRAGEN INC 4

4 · VIRAGEN INC · Filed Mar 22, 2007

Insider Transaction Report

Form 4
Period: 2007-03-20
Transactions
  • Sale

    Common Stock

    2007-03-20$0.05/sh398,650$19,93335,064,689 total
  • Sale

    Common Stock

    2007-03-21$0.02/sh20,500,000$485,8509,499,900 total
  • Sale

    Common Stock

    2007-03-20$0.05/sh74,300$3,71535,463,339 total
  • Sale

    Common Stock

    2007-03-21$0.02/sh5,064,789$112,94529,999,900 total
Footnotes (1)
  • [F1]Alexandra Global Master Fund Ltd. ("Alexandra") is the direct beneficial owner of the securities. Alexandra Investment Management, LLC ("AIM") is the investment advisor to Alexandra. Mikhail Filimonov is the Chairman, Chief Executive Officer, Chief Investment Officer and a Managing Member of AIM. By reason of these relationships, AIM and Mikhail Filimonov may be deemed to beneficially own the securities beneficially owned by Alexandra. AIM and Mikhail Filimonov each disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interests therein.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT